ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

DYAI Dyadic International Inc

1,43
-0,07 (-4,67%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Dyadic International Inc DYAI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,07 -4,67% 1,43 06:00:08
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,48 1,40 1,4999 1,43 1,50
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202422:30GLOBEDyadic to Report First Quarter 2024 Financial Results on..
28.3.202421:00GLOBEDyadic Reports 2023 Full Year Results and Recent Company..
28.3.202413:30GLOBEDyadic Announces Change in Board and Management Leadership..
27.3.202413:30GLOBEDyadic to Attend Industry Events in April
26.3.202413:30GLOBEDyadic Announces Publication of C1 Monoclonal Antibody in..
21.3.202413:30GLOBEDyadic to Attend Future Food Tech Event March 21 – 22, 2024..
14.3.202421:30GLOBEDyadic to Report Full Year 2023 Financial Results and Host..
11.3.202414:57GLOBECORRECTION – Dyadic Announces Closing of Private Placement..
11.3.202413:45EDGAR2Form 8-K - Current report
11.3.202413:30GLOBEDyadic Announces Closing of Private Placement of $6.0..
01.3.202414:30GLOBEDyadic to Attend Industry Events in March
28.2.202414:30GLOBEDyadic Announces Strategic Partnership Agreement to..
21.2.202414:30GLOBEDyadic Advances Collaboration with Israel Institute for..
13.2.202422:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202414:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
06.2.202414:30GLOBEDyadic Announces Research and Development Collaboration..
01.2.202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202414:30GLOBEDyadic to Attend BIO CEO & Investor Conference and European..
05.1.202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202414:30GLOBEDyadic to Attend J.P. Morgan 42nd Annual Healthcare..
30.11.202314:30GLOBEDyadic Attends Investor Events in December
29.11.202314:30GLOBEDyadic Announces Top-Line Results from its Successful Phase..
20.11.202314:30GLOBEDyadic’s C1 Platform to be Used to Produce Vaccines..
08.11.202322:09EDGAR2Form 8-K - Current report
08.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:00GLOBEDyadic Announces Third Quarter 2023 Financial Results and..
30.10.202313:30GLOBEDyadic to Present at Industry Events in November
25.10.202322:30GLOBEDyadic to Report Third Quarter 2023 Financial Results on..
09.10.202314:30GLOBEDyadic Appoints Doug Pace to Its Executive Leadership Team
06.10.202322:20EDGAR2Form 8-K - Current report
06.10.202322:10EDGAR2Form 8-K - Current report
05.10.202314:30GLOBEDyadic’s C1 Platform Selected by the Vaccine and..
29.9.202314:30GLOBEDyadic to Present at Industry and Investor Events in October
26.9.202314:30GLOBEDyadic and bYoRNA Announce a Collaboration Targeting the..
19.9.202314:30EDGAR2Form 8-K - Current report
19.9.202314:00GLOBEDyadic Announces Development and License Agreement to..
12.9.202322:30GLOBEDyadic to Present at BioProcess International
28.8.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
09.8.202322:10EDGAR2Form S-3 - Registration statement under Securities Act of..
09.8.202322:08EDGAR2Form 8-K - Current report
09.8.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Kürzlich von Ihnen besucht

Delayed Upgrade Clock